NURIX THERAPEUTICS, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations
NURIX THERAPEUTICS, INC. (NRIX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations of $901.00 thousand as of 2022-08-31, per its 10-Q filed 2022-10-06.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations · last filed 2022-10-06
- 2022-08-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $901.00K.
- 2022-05-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $901.00K.
- 2022-02-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $901.00K.
- 2021-11-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations $286.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations |
|---|---|
| 2022-08-31 | $901.00K 10-Q · filed 2022-10-06 |
| 2022-05-31 | $901.00K 10-Q · filed 2022-07-07 |
| 2022-02-28 | $901.00K 10-Q · filed 2022-04-08 |
| 2021-11-30 | $286.00K 10-K · filed 2022-01-28 |
| 2021-08-31 | $286.00K 10-Q · filed 2022-10-06 |
| 2021-05-31 | $170.00K 10-Q · filed 2022-07-07 |
| 2021-02-28 | $170.00K 10-Q · filed 2022-04-08 |
| 2020-11-30 | $170.00K 10-K · filed 2022-01-28 |
| 2020-08-31 | $170.00K 10-Q · filed 2021-10-14 |
| 2020-05-31 | $170.00K 10-Q · filed 2021-07-13 |
| 2020-02-29 | $170.00K 10-Q · filed 2021-04-13 |
| 2019-11-30 | $170.00K 10-K · filed 2022-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |